Tech Company Financing Transactions
TVA Medical Funding Round
TVA Medical, based in Austin, raised $15 million from Baxter Ventures, Boston Scientific Corporation and S3 Ventures.
Transaction Overview
Company Name
Announced On
10/6/2015
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series C
Investors
Proceeds Purpose
The investment round will support continuation of clinical activities and acceleration of market development for the everlinQ endoAVF System, a catheter-based technology designed to create hemodialysis access for chronic kidney disease patients in a minimally invasive procedure. Funds will support the ongoing Novel Endovascular Access Trial (NEAT) clinical study (12-month follow up to complete in 2016) and additional global clinical research, as well as device reimbursement and market access initiatives.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7000 Bee Cave Rd. 250
Austin, TX 78746
USA
Austin, TX 78746
USA
Phone
Website
Email Address
Overview
TVA Medical, Inc. (TVA) is a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Berman
Chief Financial Officer
Alfred Macdaniel
VP - Bus. Development
Michael McCully
VP - Marketing
Michelle Machuca
VP - Operations
Philip Tetzlaff
VP - R & D
Philip Tetzlaff
VP - Regulatory Affairs
Noah Bartsch
Browse more venture capital transactions:
Prev: 10/6/2015: Inventables venture capital transaction
Next: 10/6/2015: Precision Biopsy venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs